Supplemental Conditionally Essential Nutrients in Cardiovascular Disease Therapy

  title={Supplemental Conditionally Essential Nutrients in Cardiovascular Disease Therapy},
  author={Barry S. Kendler},
  journal={The Journal of Cardiovascular Nursing},
  • B. Kendler
  • Published 1 January 2006
  • Biology, Medicine
  • The Journal of Cardiovascular Nursing
Conditionally essential nutrients (CENs) are organic compounds that are ordinarily produced by the body in amounts sufficient to meet its physiological requirements. However, in disorders, such as cardiovascular disease (CVD), and in other physiologically stressful conditions, their biosynthesis may be inadequate. Under these circumstances, CENs become essential nutrients, comparable to vitamins. The CENs of primary importance in CVD, based on the quantity and quality of human clinical studies… 
Micronutrient deficiencies an unmet need in heart failure.
Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
The outcomes of interest were CVD clinical events and major CVD risk factors, adverse effects and costs, and four trials that investigated CoQ10 supplementation in patients on statin therapy showed that simultaneous administration of Co Q10 did not significantly influence lipid levels or systolic blood pressure.
The management of conditioned nutritional requirements in heart failure
It is believed that conditioned nutritional requirements, if unsatisfied, contribute to myocyte dysfunction and loss; thus, restoration of nutritional deficiencies should be part of the overall therapeutic strategy for patients with congestive heart failure.
Coenzyme Q-10 in Human Health: Supporting Evidence?
Abstract Coenzyme Q-10 (CoQ10) is a widely used alternative medication or dietary supplement and one of its roles is as an antioxidant. It naturally functions as a coenzyme and component of oxidative
Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes.
It is suggested that dietary supplementation of taurine attenuates diabetes-induced changes in cardiac contractile function and ultrastructure without any alterations in plasma lipid and glucose levels.
Nutritional Management of Cardiovascular Complications Caused by Diabetes
This chapter is intended to highlight the impact of the nutritional experience of the developing fetus and describe the role of epigenetics and maternal nutrition on the risk of developing diabetes and cardiovascular complications.
Enhanced aerobic exercise performance in women by a combination of three mineral Chelates plus two conditionally essential nutrients
A combination of certain mineral complexes plus two CENs improved aerobic exercise performance in fit young adult women.
Coenzyme Q 10 supplementation reduces oxidative stress and increase antioxidant enzyme activity in patients with coronary artery disease
Coenzyme Q10 supplements at a dose of 150 mg can decrease oxidative stress and increase antioxidant enzyme activity in patients with CAD and a higher dose of coenzymeQ10 supplements (>150 mg/d) might promote rapid and sustainable antioxidation in patientswith CAD.
An Unmet Need in Heart Failure
Heart failure (HF) is a common, disabling, and costly disease. Despite major advances in medical therapy, morbidityand mortality remain high, in part because current pharmacological regimens may not
Disruption of the Nitric Oxide Signaling System in Diabetes
The purpose of this chapter is to review current information about the disruption of this important signaling system especially in the context of diabetes.


Perspectives on therapy of cardiovascular diseases with oenzyme Q10 (Ubiquinone)
Double-blind placebo-controlled trials have definitely confirmed that coenzyme Q10 has a place as adjunctive treatment in heart failure with beneficial effects on the clinical outcome, the patients' physical activity, and their quality of life.
The benefits of ribose in cardiovascular disease.
Vascular effects of dietary L-arginine supplementation.
Use of alternative pharmacotherapy in management of cardiovascular diseases.
Antioxidants have not been consistently proven beneficial in reducing cardiovascular mortality and the benefits of APs as part of the treatment for CVD are controversial.
Carnitine and its derivatives in cardiovascular disease.
  • M. Arsenian
  • Medicine, Biology
    Progress in cardiovascular diseases
  • 1997
Arginine needs, physiological state and usual diets. A reevaluation.
Evidence is discussed that puts in question the widely held belief that adult mammals, including human beings, can meet all of their arginine needs by endogenous synthesis. Arginine, used in
Coenzyme Q10 and cardiovascular disease: a review.
  • B. Sarter
  • Medicine
    The Journal of cardiovascular nursing
  • 2002
It appears that levels of coenzyme Q10 are decreased during therapy with HMG-CoA reductase inhibitors, gemfibrozil, Adriamycin, and certain beta blockers, but because of its low toxicity it may be appropriate to recommend coen enzyme Q10 to select patients as an adjunct to conventional treatment.
Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.